Literature DB >> 22855707

B cell memory to a serogroup C meningococcal conjugate vaccine in childhood and response to booster: little association with serum IgG antibody.

Kirsten P Perrett1, Celina Jin, Elizabeth Clutterbuck, Tessa M John, Amy P Winter, Elizabeth Kibwana, Ly-Mee Yu, Nigel Curtis, Andrew J Pollard.   

Abstract

The maintenance of adequate serum Ab levels following immunization has been identified as the most important mechanism for individual long-term protection against rapidly invading encapsulated bacteria. The mechanisms for maintaining adequate serum Ab levels and the relationship between Ag-specific memory B cells and Ab at steady state are poorly understood. We measured the frequency of circulating serogroup C meningococcal (MenC)-specific memory B cells in 250 healthy 6- to 12-y-old children 6 y following MenC conjugate vaccine priming, before a booster of a combined Haemophilus influenzae type b-MenC conjugate vaccine and then 1 wk, 1 mo, and 1 y after the booster. We investigated the relationship between circulating MenC-specific memory B cell frequencies and Ab at baseline and following the booster vaccine. We found very low frequencies of circulating MenC-specific memory B cells at steady state in primary school-aged children and little association with MenC IgG Ab levels. Following vaccination, there were robust memory B cell booster responses that, unlike Ab levels, were not dependent on age at priming with MenC. Measurement of B cell memory in peripheral blood does not predict steady state Ab levels nor the capacity to respond to a booster dose of MenC Ag.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22855707     DOI: 10.4049/jimmunol.1200451

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Polysaccharide-specific B cell responses to vaccination in humans.

Authors:  Ruth Mitchell; Dominic F Kelly; Andrew J Pollard; Johannes Trück
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

Review 2.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

Authors:  Juan Gea-Banacloche; Krishna V Komanduri; Paul Carpenter; Sophie Paczesny; Stefanie Sarantopoulos; Jo-Anne Young; Nahed El Kassar; Robert Q Le; Kirk R Schultz; Linda M Griffith; Bipin N Savani; John R Wingard
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-14       Impact factor: 5.742

3.  Antibody avidity in humoral immune responses in Bangladeshi children and adults following administration of an oral killed cholera vaccine.

Authors:  Mohammad Murshid Alam; Daniel T Leung; Marjahan Akhtar; Mohammad Nazim; Sarmin Akter; Taher Uddin; Farhana Khanam; Deena Al Mahbuba; Shaikh Meshbahuddin Ahmad; Taufiqur Rahman Bhuiyan; Stephen B Calderwood; Edward T Ryan; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2013-08-07

4.  Immunogenicity and Reactogenicity of a Reduced Schedule of a 4-component Capsular Group B Meningococcal Vaccine: A Randomized Controlled Trial in Infants.

Authors:  Marta Valente Pinto; Daniel O'Connor; Ushma Galal; Elizabeth A Clutterbuck; Hannah Robinson; Emma Plested; Sagida Bibi; Susana Camara Pellisso; Harri Hughes; Simon Kerridge; Yama F Mujadidi; Helen Findlow; Ray Borrow; Matthew D Snape; Andrew J Pollard
Journal:  Open Forum Infect Dis       Date:  2020-04-29       Impact factor: 3.835

5.  Human Infant Memory B Cell and CD4+ T Cell Responses to HibMenCY-TT Glyco-Conjugate Vaccine.

Authors:  Angela Fuery; Peter C Richmond; Andrew J Currie
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

6.  Differential B-cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine.

Authors:  Els van Westen; Alienke J Wijmenga-Monsuur; Harry H van Dijken; Jacqueline A M van Gaans-van den Brink; Betsy Kuipers; Mirjam J Knol; Guy A M Berbers; Elisabeth A M Sanders; Nynke Y Rots; Cécile A C M van Els
Journal:  Clin Infect Dis       Date:  2015-04-01       Impact factor: 9.079

7.  Different Dynamics for IgG and IgA Memory B Cells in Adolescents following a Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster Vaccination Nine Years after Priming: A Role for Priming Age?

Authors:  Susanne P Stoof; Anne-Marie Buisman; Debbie M van Rooijen; Rianne Boonacker; Fiona R M van der Klis; Elisabeth A M Sanders; Guy A M Berbers
Journal:  PLoS One       Date:  2015-10-12       Impact factor: 3.240

8.  An Explorative Biomarker Study for Vaccine Responsiveness after a Primary Meningococcal Vaccination in Middle-Aged Adults.

Authors:  Marieke van der Heiden; Guy A M Berbers; Susana Fuentes; Menno C van Zelm; Annemieke M H Boots; Anne-Marie Buisman
Journal:  Front Immunol       Date:  2018-01-11       Impact factor: 7.561

9.  Novel Intervention in the Aging Population: A Primary Meningococcal Vaccine Inducing Protective IgM Responses in Middle-Aged Adults.

Authors:  Marieke van der Heiden; Annemieke M H Boots; Axel A Bonacic Marinovic; Lia G H de Rond; Marjan van Maurik; Irina Tcherniaeva; Guy A M Berbers; Anne-Marie Buisman
Journal:  Front Immunol       Date:  2017-07-19       Impact factor: 7.561

Review 10.  The Role of Serotype-Specific Immunological Memory in Pneumococcal Vaccination: Current Knowledge and Future Prospects.

Authors:  Ioanna Papadatou; Irene Tzovara; Paul V Licciardi
Journal:  Vaccines (Basel)       Date:  2019-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.